REMEDENT, INC.·4/A

Dec 29, 2:33 PM ET

REMEDENT, INC. 4/A

4/A · REMEDENT, INC. · Filed Dec 29, 2008

Insider Transaction Report

Form 4/AAmended
Period: 2008-12-17
Ross Stephen Farley
DirectorCFO; Secretary
Transactions
  • Purchase

    Common Stock

    2008-12-17$0.45/sh+5,000$2,250461,277 total
Footnotes (1)
  • [F1]This Amendment is being filed to correct the amount of Non-Derivative securities beneficially owned in Table 1 as originally disclosed in the report filed December 19, 2008, which mistakenly included addition of the Reporting Person's beneficial ownership of Derivative Securities.

Documents

1 file
  • 4
    amend121908_ex.xml